To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
Languages
Recent
Show all languages
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
.
Leo
Newton
Brights
Milds

From Wikipedia, the free encyclopedia

Abelacimab
Monoclonal antibody
TypeWhole antibody
TargetFactor XI and its active form Factor XIa
Clinical data
Other namesMAA868
AHFS/Drugs.comMonograph
License data
Routes of
administration
Intravenous
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
ChemSpider
  • none
KEGG

Abelacimab (MAA868), is a fully human monoclonal antibody for the treatment of coagulation,[1] under development by Anthos Therapeutics.

YouTube Encyclopedic

  • 1/5
    Views:
    882
    405
    4 221
    1 721
    487
  • Abelacimab for prevention of venous thromboembolism. NEJM 2021
  • AVATAR Trial. Aortic valve surgery in Asymptomatic Severe Aortic Stenosis. AHA-2021
  • Przyszłość w leczeniu migotania–wziewne leki antyarytmiczne,nowe leki przeciwkrzepliwe,ablacja,inne
  • FAME 3 Trial. FFR guided PCI Vs CABG in three vessel CAD
  • Revascularization in Stable Coronary Artery Disease. Lessons from ISCHEMIA, COURAGE, FREEDOM, ORBITA

Transcription

Mechanism of action

It is anti-factor XI antibody.[1][2]

See also

References

  1. ^ a b Verhamme P, Yi BA, Segers A, Salter J, Bloomfield D, Büller HR, et al. (August 2021). "Abelacimab for Prevention of Venous Thromboembolism". The New England Journal of Medicine. 385 (7): 609–617. doi:10.1056/NEJMoa2105872. PMID 34297496. S2CID 236198598.
  2. ^ "Atrial Fibrillation Study with Abelacimab Stopped Early by the Data Monitoring Committee Due to an Overwhelming Reduction in Bleeding as Compared to a DOAC (Direct Oral Anticoagulant)". Business Wire. 18 September 2023.


This page was last edited on 9 March 2024, at 08:53
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.